CVRX (NASDAQ: CVRX) revenue
CVRX reported revenue of $56.7m for fiscal 2025, 10.4% more than in fiscal 2024 ($51.3m). Since fiscal 2020 its revenue has grown by 835.9%, an average growth of 56.4% a year.
CVRX has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 6 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $56.7m | +10.4% | −$51.3m | −90.5% |
| 2024 | $51.3m | +30.5% | −$59.5m | −116.0% |
| 2023 | $39.3m | +74.9% | −$43.1m | −109.7% |
| 2022 | $22.5m | +72.4% | −$42.5m | −189.3% |
| 2021 | $13.0m | +115.4% | −$26.0m | −199.2% |
| 2020 | $6.1m | — | −$11.5m | −190.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
CVRX revenue compared with its sector
By revenue for its latest fiscal year, CVRX ranks 321st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; CVRX, 10.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 319th | Nuvation Bio | $62.9m | 699.0% |
| 320th | Tango Therapeutics | $62.4m | 48.3% |
| 321st | CVRX | $56.7m | 10.4% |
| 322nd | 908 Devices | $56.2m | 17.7% |
| 323rd | Nektar Therapeutics | $55.2m | −43.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of CVRX
- How much revenue did CVRX make in fiscal 2025?
- CVRX reported revenue of $56.7m for fiscal 2025, compared with $51.3m in fiscal 2024.
- How much has the revenue of CVRX grown?
- Between fiscal 2020 and fiscal 2025 it went from $6.1m to $56.7m: 835.9% more, an average growth of 56.4% a year.
- What was the best year for revenue at CVRX?
- Of its last 6 fiscal years, fiscal 2025, with $56.7m.
- Where does CVRX rank in its sector by revenue?
- It ranks 321st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for CVRX come from?
- From the annual report (Form 10-K) that CVRX files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that CVRX files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on CVRX: the CVRX page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.